{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:33:51Z","timestamp":1791178431687,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ahj.2007.12.035","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T14:03:22Z","timestamp":1204898602000},"page":"106-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration"],"prefix":"10.1016","volume":"156","author":[{"given":"Matt","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Knappertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8 Suppl","key":"10.1016\/j.ahj.2007.12.035_bib1","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.jacc.2005.10.066","article-title":"C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2007.12.035_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.CIR.0000129507.12719.80","article-title":"CRP as a mediator of disease","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.0000079160.07364.6A","article-title":"C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study","volume":"108","author":"Cao","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.12.035_bib6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.12.035_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib8","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1001\/archinte.163.17.2006","article-title":"An update on aspirin in the primary prevention of cardiovascular disease","volume":"163","author":"Eidelman","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2007.12.035_bib9","first-page":"71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"524","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2007.12.035_bib10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(03)00897-X","article-title":"Influence of aspirin on inflammatory markers in patients after acute myocardial infarction","volume":"92","author":"Solheim","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.12.035_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0002-9149(03)00549-6","article-title":"Effects of aspirin (325 mg\/day) on serum high-sensitivity C-reactive protein, cytokines, and adhesion molecules in healthy volunteers","volume":"92","author":"Azar","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2007.12.035_bib13","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0735-1097(01)01289-X","article-title":"Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay","volume":"37","author":"Feldman","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2007.12.035_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1018644212794","article-title":"Effect of short-term aspirin use on C-reactive protein","volume":"9","author":"Feng","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ahj.2007.12.035_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2007.12.035_bib16","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","article-title":"Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction","volume":"106","author":"Plenge","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib19","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1067\/mhj.2003.34","article-title":"Effect of atorvastatin and pravastatin on serum C-reactive protein","volume":"145","author":"Kent","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2007.12.035_bib20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archinte.164.1.40","article-title":"Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease","volume":"164","author":"Hennekens","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2007.12.035_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000086678","article-title":"The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study: objectives and design","volume":"25","author":"Howard","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ahj.2007.12.035_bib23","series-title":"Applied linear statistical models","author":"Neter","year":"2004"},{"key":"10.1016\/j.ahj.2007.12.035_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cardiores.2004.07.002","article-title":"Aspirin inhibits ox-LDL\u2013mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells","volume":"64","author":"Mehta","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2007.12.035_bib25","first-page":"340A","article-title":"Combination of aspirin and pravastatin dramatically reduces oxidative stress and the expression of LOX-1 and adhesion molecules: novel insight into the mechanism of action of aspirin and statins [abstract]","volume":"47","author":"Chen","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2007.12.035_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.ATV.0000201073.45862.8b","article-title":"Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins","volume":"26","author":"Hofnagel","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2007.12.035_bib27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000066685.13434.FA","article-title":"LOX-1, an oxidized LDL endothelial receptor, induces CD40\/CD40L signaling in human coronary artery endothelial cells","volume":"23","author":"Li","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2007.12.035_bib28","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1248\/bpb.28.1630","article-title":"Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells","volume":"28","author":"Lin","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ahj.2007.12.035_bib29","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2007.12.035_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0705907","article-title":"Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action","volume":"143","author":"Taubert","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ahj.2007.12.035_bib31","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308000768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870308000768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:35:52Z","timestamp":1757568952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870308000768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0002870308000768"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2007.12.035","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2007.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}